Literature DB >> 1645667

Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.

R Kozlik1, H H Kramer, H Wicht, A Krian, J Ostermeyer, D Reinhardt.   

Abstract

Twenty-six infants and children with congenital heart disease (CHD) undergoing cardiac surgery were investigated for alterations in myocardial beta-adrenoceptor density. The patients were divided into three groups according to type and severity of CHD: group I consisted of 6 patients with acyanotic shunt lesions of moderate severity; group II comprised 13 children with severe acyanotic shunt and valve lesions and group III included 7 children with cyanotic CHD. The myocardial beta-adrenoceptor density was determined using (-)3-[125I]Iodocyanopindolol [( 125I]ICYP) and was reduced by approximately 50% in severe acyanotic CHD (33.6 fmol/mg protein) and cyanotic CHD (35.3 fmol/mg protein) in comparison with the group with less severe acyanotic shunt defects (64.4 fmol/mg protein). The affinity dissociation constant (Kd.ICYP) did not differ statistically between the groups. The proportion of beta 1- and beta 2-subpopulations was evaluated by ICI 118,551-[125I]ICYP competition studies. In group II (61.5%) and group III (69.1%) significant lower portions of beta 1-adrenoceptors were found compared with group I (78.2%). This shift of subpopulations was due to a decreased beta 1-receptor density while beta 2-receptor density was unchanged in all groups. While the plasma noradrenaline levels of group I were similar to those of a control group of 13 healthy children, respective values of group II and III were significantly elevated. A significant negative correlation was found between plasma noradrenaline levels and myocardial beta-adrenoceptor density. It is concluded that exposure of these receptors to increased circulating catecholamines, due to an enhanced sympathetic tone, leads to a reduction of their density.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645667     DOI: 10.1007/bf02093715

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  46 in total

Review 1.  Regulation of beta-adrenergic receptors: impaired desensitization in myocardial ischemia.

Authors:  R H Strasser; J Krimmer; R Marquetant
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

2.  Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.

Authors:  M Böhm; D Beuckelmann; L Brown; G Feiler; B Lorenz; M Näbauer; B Kemkes; E Erdmann
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

3.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

Review 5.  Beta-adrenergic function in heart muscle disease and heart failure.

Authors:  M R Bristow; N E Kantrowitz; R Ginsburg; M B Fowler
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

6.  Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.

Authors:  M R Bristow; R E Hershberger; J D Port; W Minobe; R Rasmussen
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

7.  Postnatal development of adrenergic responsiveness in the rabbit heart.

Authors:  Z P Feng; W F Dryden; T Gordon
Journal:  Can J Physiol Pharmacol       Date:  1989-08       Impact factor: 2.273

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure.

Authors:  K Swedberg; C Viquerat; J L Rouleau; M Roizen; B Atherton; W W Parmley; K Chatterjee
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

10.  Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.

Authors:  D S Goldstein
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

View more
  7 in total

1.  Beta-adrenoceptor density on mononuclear leukocytes and right atrial myocardium in infants and children with congenital heart disease.

Authors:  R Kozlik; H H Kramer; H Wicht; W Bircks; D Reinhardt
Journal:  Klin Wochenschr       Date:  1991-12-11

2.  The myocardial profile of the cytosolic isozymes of creatine kinase is apparently not related to cyanosis in congenital heart disease.

Authors:  G Kessler-Icekson; E Birk; H Schlesinger; Y Barhum; N Ad; M Friedman; B A Vidne
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

Review 3.  Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?

Authors:  Luke A Bruns; Charles E Canter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Maximising the clinical use of exercise gaseous exchange testing in children with repaired cyanotic congenital heart defects: the development of an appropriate test strategy.

Authors:  A McManus; M Leung
Journal:  Sports Med       Date:  2000-04       Impact factor: 11.136

5.  Role of β-blocker therapy in pediatric heart failure.

Authors:  Akash R Patel; Robert E Shaddy
Journal:  Ped Health       Date:  2010

Review 6.  Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure.

Authors:  Giuseppe Distefano; Pietro Sciacca
Journal:  Ital J Pediatr       Date:  2012-09-12       Impact factor: 2.638

7.  Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children.

Authors:  Mehdi Oualha; Saïk Urien; Odile Spreux-Varoquaux; Alice Bordessoule; Irène D'Agostino; Philippe Pouard; Jean-Marc Tréluyer
Journal:  Crit Care       Date:  2014-01-24       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.